HIGHLIGHTS
- who: Sunil Kumar et al. from the Department of Biological Sciences, Sungkyunkwan University, Jangan-gu, Suwon, Gyeonggi-do, Korea have published the Article: Immunotherapeutic Potential of m6A-Modifiers and MicroRNAs in Controlling Acute Myeloid Leukaemia, in the Journal: Biomedicines 2021, 9, 690. of /2021/
- what: In this review, the authors have described the potential of m6A-modifiers in developing cancer precision medicines and explained how ‘epitranscriptomics' plays a central role in regulating the crucial genes associated with AML.
SUMMARY
Vu et_al, 2017 have demonstrated the role of m6A writer enzyme ‘Mettl3 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.